BIOMAT Database Logo BIOMAT Database Logo

Two novel mutations involved in hereditary tyrosinemia type I. 1995

M St-Louis, and J Poudrier, and D Phaneuf, and B Leclerc, and R Laframboise, and R M Tanguay
Laboratoire de Génétique Cellulaire et Développementale, Université Laval, Ste-Foy, Québec, Canada.

UI MeSH Term Description Entries
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008297 Male Males
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D009664 Norway A country located in northern Europe, bordering the North Sea and the Atlantic Ocean, west of Sweden. The capital is Oslo. Kingdom of Norway
D010455 Peptides Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of peptides that can form into complex structures such as ENZYMES and RECEPTORS. Peptide,Polypeptide,Polypeptides
D002170 Canada The largest country in North America, comprising 10 provinces and three territories. Its capital is Ottawa.
D004247 DNA A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine). DNA, Double-Stranded,Deoxyribonucleic Acid,ds-DNA,DNA, Double Stranded,Double-Stranded DNA,ds DNA
D005091 Exons The parts of a transcript of a split GENE remaining after the INTRONS are removed. They are spliced together to become a MESSENGER RNA or other functional RNA. Mini-Exon,Exon,Mini Exon,Mini-Exons

Related Publications

M St-Louis, and J Poudrier, and D Phaneuf, and B Leclerc, and R Laframboise, and R M Tanguay
Two novel FAH gene mutations in a patient with hereditary tyrosinemia type I.
January 2014, Annals of clinical and laboratory science,
M St-Louis, and J Poudrier, and D Phaneuf, and B Leclerc, and R Laframboise, and R M Tanguay
[Hereditary tyrosinemia type I].
January 1998, Ryoikibetsu shokogun shirizu,
M St-Louis, and J Poudrier, and D Phaneuf, and B Leclerc, and R Laframboise, and R M Tanguay
Six novel mutations in the fumarylacetoacetate hydrolase gene of patients with hereditary tyrosinemia type I.
January 1996, Human mutation,
M St-Louis, and J Poudrier, and D Phaneuf, and B Leclerc, and R Laframboise, and R M Tanguay
Mutations in the fumarylacetoacetate hydrolase gene causing hereditary tyrosinemia type I: overview.
January 1997, Human mutation,
M St-Louis, and J Poudrier, and D Phaneuf, and B Leclerc, and R Laframboise, and R M Tanguay
Hereditary tyrosinemia type I--an overview.
January 1986, Scandinavian journal of clinical and laboratory investigation. Supplementum,
M St-Louis, and J Poudrier, and D Phaneuf, and B Leclerc, and R Laframboise, and R M Tanguay
Chromosomal instability in hereditary tyrosinemia type I.
January 1990, Pediatric pathology,
M St-Louis, and J Poudrier, and D Phaneuf, and B Leclerc, and R Laframboise, and R M Tanguay
Chromosomal instability in hereditary tyrosinemia type I.
January 1994, Pediatric pathology,
M St-Louis, and J Poudrier, and D Phaneuf, and B Leclerc, and R Laframboise, and R M Tanguay
In vivo suppressor mutations correct a murine model of hereditary tyrosinemia type I.
October 1999, Proceedings of the National Academy of Sciences of the United States of America,
M St-Louis, and J Poudrier, and D Phaneuf, and B Leclerc, and R Laframboise, and R M Tanguay
[One case of hereditary tyrosinemia type I].
April 2003, Zhonghua er ke za zhi = Chinese journal of pediatrics,
M St-Louis, and J Poudrier, and D Phaneuf, and B Leclerc, and R Laframboise, and R M Tanguay
Visceral pathology of hereditary tyrosinemia type I.
August 1990, American journal of human genetics,
Copied contents to your clipboard!